Cargando…

Physical Agent-Based Treatments for Overactive Bladder: A Review

Almost one-fifth of the people in the world experience a decrease in quality of life due to overactive bladder (OAB) syndrome. The main bothersome symptoms are urgency accompanied by urinary frequency and nocturia. This chronic, disabling condition is first managed by reducing fluid intake and pelvi...

Descripción completa

Detalles Bibliográficos
Autores principales: Khasanah, Nurida, Chin, Hung-Yen, Peng, Chih-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456779/
https://www.ncbi.nlm.nih.gov/pubmed/36079076
http://dx.doi.org/10.3390/jcm11175150
_version_ 1784785903182413824
author Khasanah, Nurida
Chin, Hung-Yen
Peng, Chih-Wei
author_facet Khasanah, Nurida
Chin, Hung-Yen
Peng, Chih-Wei
author_sort Khasanah, Nurida
collection PubMed
description Almost one-fifth of the people in the world experience a decrease in quality of life due to overactive bladder (OAB) syndrome. The main bothersome symptoms are urgency accompanied by urinary frequency and nocturia. This chronic, disabling condition is first managed by reducing fluid intake and pelvic floor muscle training, supplemented with antimuscarinic drugs, if necessary. However, refractory cases often still occur. In more severe cases, invasive surgical interventions can be considered; yet, the success rate is still inconsistent, and there is a high complication rate. This condition is frustrating for patients and challenging for the medical staff involved. Although its pathophysiology has not been fully elucidated, peripheral autonomic somatic and sensory afferent receptors are considered to be involved in this condition. Hence, currently, physical agent-based treatments such as neuromodulation have taken a significant place in the third-line therapy of OAB. The efficacy and safety profiles of electrical and magnetic stimulation continue to evolve. Physical-based agents provide an appealing option owing to their effectiveness and minimal side effects. In addition, more physical therapies using light and shock energy are currently being investigated. Thus, a comprehensive understanding of these modalities is an extremely important aspect to provide the most suitable modalities for patients.
format Online
Article
Text
id pubmed-9456779
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94567792022-09-09 Physical Agent-Based Treatments for Overactive Bladder: A Review Khasanah, Nurida Chin, Hung-Yen Peng, Chih-Wei J Clin Med Review Almost one-fifth of the people in the world experience a decrease in quality of life due to overactive bladder (OAB) syndrome. The main bothersome symptoms are urgency accompanied by urinary frequency and nocturia. This chronic, disabling condition is first managed by reducing fluid intake and pelvic floor muscle training, supplemented with antimuscarinic drugs, if necessary. However, refractory cases often still occur. In more severe cases, invasive surgical interventions can be considered; yet, the success rate is still inconsistent, and there is a high complication rate. This condition is frustrating for patients and challenging for the medical staff involved. Although its pathophysiology has not been fully elucidated, peripheral autonomic somatic and sensory afferent receptors are considered to be involved in this condition. Hence, currently, physical agent-based treatments such as neuromodulation have taken a significant place in the third-line therapy of OAB. The efficacy and safety profiles of electrical and magnetic stimulation continue to evolve. Physical-based agents provide an appealing option owing to their effectiveness and minimal side effects. In addition, more physical therapies using light and shock energy are currently being investigated. Thus, a comprehensive understanding of these modalities is an extremely important aspect to provide the most suitable modalities for patients. MDPI 2022-08-31 /pmc/articles/PMC9456779/ /pubmed/36079076 http://dx.doi.org/10.3390/jcm11175150 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Khasanah, Nurida
Chin, Hung-Yen
Peng, Chih-Wei
Physical Agent-Based Treatments for Overactive Bladder: A Review
title Physical Agent-Based Treatments for Overactive Bladder: A Review
title_full Physical Agent-Based Treatments for Overactive Bladder: A Review
title_fullStr Physical Agent-Based Treatments for Overactive Bladder: A Review
title_full_unstemmed Physical Agent-Based Treatments for Overactive Bladder: A Review
title_short Physical Agent-Based Treatments for Overactive Bladder: A Review
title_sort physical agent-based treatments for overactive bladder: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456779/
https://www.ncbi.nlm.nih.gov/pubmed/36079076
http://dx.doi.org/10.3390/jcm11175150
work_keys_str_mv AT khasanahnurida physicalagentbasedtreatmentsforoveractivebladderareview
AT chinhungyen physicalagentbasedtreatmentsforoveractivebladderareview
AT pengchihwei physicalagentbasedtreatmentsforoveractivebladderareview